SCHEMBL1170979

SCHEMBL1170979

CC(C)(S)C(=O)OCC(COCC(COC(=O)C(C)(C)S)(COC(=O)C(C)(C)S)COC(=O)C(C)(C)S)(COC(=O)C(C)(C)S)COC(=O)C(C)(C)S

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.31
HIF1A Q16665 1/20 0.31
THRB P10828 1/20 0.31
MMP8 P22894 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1171107 0.93 MAPK1 (0.34) MAPK1HIF1AMMP8
SCHEMBL1502718 0.83 THRB (0.38) MAPK1HIF1ATHRBMMP8
SCHEMBL31453982 0.83 ALDH1A1 (0.41) MAPK1HIF1A
SCHEMBL1304382 0.83 ALDH1A1 (0.45) MAPK1HIF1A
SCHEMBL12561800 0.82 PRKCA (0.39) MAPK1HIF1ATHRB
SCHEMBL3095013 0.79 LMNA (0.39)
SCHEMBL4540183 0.78 MAPK1 (0.35) MAPK1HIF1ATHRB
SCHEMBL26974017 0.77 MAPK1 (0.35) MAPK1HIF1ATHRB
SCHEMBL24049312 0.76 PRKCA (0.37) MMP8
SCHEMBL14262753 0.76 ALDH1A1 (0.37) THRBMMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637544-B2 UV curable silicone composition and cured product thereof DUROPTIX MATERIALS KABUSHIKI KAISHA (JP) 2026-05-26 US disclosed
CN-122095275-A Method for manufacturing wavelength conversion sheet 2026-05-26 CN disclosed
CN-122070502-A Wavelength conversion sheet, and backlight and liquid crystal display device using same 大日本印刷株式会社 2026-05-19 CN disclosed
US-12624279-B2 Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device FUJIFILM CORPORATION (JP) 2026-05-12 US disclosed
EP-4703778-A1 WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE Dai Nippon Printing Co., Ltd. (JP) 2026-03-04 EP disclosed
US-12565548-B2 Compound, polymerizable composition, and cured product FUJIFILM CORPORATION (JP) 2026-03-03 US disclosed
EP-4202505-B1 BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE IN WHICH SAME IS USED, AS WELL AS METHOD FOR SELECTING BARRIER FILM DAINIPPON PRINTING CO LTD (JP) 2026-02-18 EP disclosed
EP-4201667-B1 BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACK LIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE WHICH USE SAME DAINIPPON PRINTING CO LTD (JP) 2025-12-17 EP disclosed
US-12496802-B2 Barrier film, wavelength conversion sheet using same, backlight and liquid crystal display device DAI NIPPON PRINTING CO., LTD. (JP) 2025-12-16 US disclosed
US-12492293-B2 Multi-component systems for preparing foamed products ARKEMA FRANCE (FR) 2025-12-09 US disclosed
EP-2055726-A1 THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Showa Denko K.K. (JP) 2009-05-06 EP disclosed
US-20090023831-A1 Curable Composition Containing Thiol Compound SHOWA DENKO K.K. (JP) 2009-01-22 US disclosed
EP-1983017-A1 CURABLE COMPOSITION CONTAINING THIOL COMPOUND Showa Denko K.K. (JP) 2008-10-22 EP disclosed
EP-1629046-B1 CURABLE POLYMER COMPOUND SHOWA DENKO KK (JP) 2008-05-14 EP disclosed
US-7341828-B2 Thiol compound, photopolymerization initiator composition and photosensitive composition SHOWA DENKO K.K. (JP) 2008-03-11 US disclosed
US-20070021571-A1 Curable polymer compound SHOWA DENKO K.K. (JP) 2007-01-25 US disclosed
US-20060079593-A1 Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same SHOWA DENKO K.K. (JP) 2006-04-13 US disclosed
US-20060041053-A1 Color filter black matrix resist composition and carbon black dispersion composition used for the composition SHOWA DENKO K.K. (JP) 2006-02-23 US disclosed
US-20060036023-A1 Color filter black matrix resist composition SHOWA DENKO K.K. (JP) 2006-02-16 US disclosed
US-20050153231-A1 Thiol compound, photopolymerization initiator composition and photosensitive composition SHOWA DENKO K.K. (JP) 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637544-B2 UV curable silicone composition and cured product thereof QSOX1, MGMT, TST MAPK1 1894/4885HIF1A 1371/4885THRB 2466/4885
US-12624279-B2 Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device NLRP1, NLRP3, ALAD MAPK1 2002/4885HIF1A 2577/4885THRB 1218/4885
US-12565548-B2 Compound, polymerizable composition, and cured product SEM1, PSMA1, RER1 MAPK1 983/4885HIF1A 238/4885THRB 4087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.